GNH USA

Europe — EMA

Mitoxantron "ebewe" (Mitoxantrone)

GNH USA supplies Mitoxantron ebewe (Mitoxantrone), an antineoplastic for acute myeloid leukemia, metastatic breast cancer and non‑Hodgkin lymphoma.

Mitoxantrone

Request sourcing

1
Pack/s

What is Mitoxantrone?

Mitoxantrone, the active ingredient in Mitoxantron ebewe, is a anthracenedione antineoplastic presented as a intravenous solution for intravenous use. It treats acute myeloid leukemia, metastatic breast cancer, prostate cancer and non‑Hodgkin lymphoma in adult patients. The drug is administered under the supervision of oncologists and is indicated for patients with advanced or refractory disease where conventional therapies have limited efficacy.

GNH USA supplies Mitoxantron ebewe as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide. The company adheres to stringent quality standards and provides reliable logistics to ensure timely delivery to treatment facilities across continents.

What is Mitoxantrone used for?

Mitoxantrone is used in the treatment of hematologic malignancies and solid tumors. - Acute Myeloid Leukemia: improves remission rates in adult patients. - Metastatic Breast Cancer: provides disease control in hormone‑refractory cases. - Prostate Cancer: used in hormone‑refractory or castration‑resistant disease. - Non‑Hodgkin Lymphoma: contributes to response in relapsed or refractory disease.

What are the side effects of Mitoxantrone?

Mitoxantrone may cause a range of adverse reactions, from frequent mild events to rare serious complications.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Fatigue: generalized tiredness. - Myelosuppression: reduced blood cell counts. - Alopecia: reversible hair loss.

Serious or Rare Side Effects: - Cardiotoxicity: potential irreversible heart damage. - Secondary leukemia: risk of therapy‑related acute leukemia. - Severe infection: due to profound neutropenia.

What precautions apply to Mitoxantrone?

When using mitoxantrone, clinicians should observe several safety measures to minimize risks. - Monitor blood counts: perform regular CBC to detect myelosuppression. - Assess cardiac function: baseline and periodic ejection fraction evaluation recommended. - Avoid concurrent cardiotoxic agents: limit use with anthracyclines or high‑dose radiation. - Pregnancy caution: use only if benefits outweigh risks; limited data available. - Handle with protective equipment: avoid skin contact and inhalation of the solution. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Mitoxantrone interact with?

Mitoxantrone can interact with other medicines, altering its efficacy or toxicity.

Major Interactions (Avoid): - Anthracyclines: combined use increases cardiotoxic risk. - Live vaccines: immunosuppression may reduce efficacy and increase infection risk. - CYP450 inhibitors: may raise plasma levels of mitoxantrone.

Moderate Interactions (Monitor Closely): - Anticoagulants: enhanced bleeding risk due to thrombocytopenia. - Other myelosuppressive agents: additive bone marrow suppression. - Radiotherapy: may exacerbate tissue toxicity.

Frequently asked questions

What is Mitoxantron ebewe used for?+
Mitoxantron ebewe contains mitoxantrone, an antineoplastic agent indicated for the treatment of adult patients with acute myeloid leukemia, metastatic breast cancer, prostate cancer and non‑Hodgkin lymphoma, particularly when disease is advanced or refractory to standard therapies.
How does mitoxantrone work?+
Mitoxantrone intercalates into DNA and stabilises the DNA‑topoisomerase II complex, preventing the enzyme from resealing DNA strands after cleavage. This leads to accumulation of DNA breaks, cell‑cycle arrest and ultimately apoptosis of rapidly proliferating cancer cells.
What is the usual dose of mitoxantrone?+
The dose of mitoxantrone is individualized and set by the prescribing oncologist based on the specific indication, patient characteristics, disease stage and treatment protocol. Clinicians determine the appropriate amount and schedule for each patient.
Is mitoxantrone safe during pregnancy or breastfeeding?+
Mitoxantrone is classified as having an unknown pregnancy category and is generally avoided during pregnancy and lactation because of potential fetal toxicity and the risk of adverse effects in the infant. Use only if the potential benefit justifies the risk.
How do I order Mitoxantron ebewe from GNH USA?+
To order, submit an enquiry on the product page at gnh-usa.com specifying the required quantity. GNH USA supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and import documentation.
How does mitoxantrone compare with other chemotherapy agents?+
Compared with traditional anthracyclines, mitoxantrone has a similar mechanism of DNA intercalation but a distinct toxicity profile, showing lower incidence of acute cardiotoxicity but a notable risk of delayed cardiac effects and secondary leukemia. Choice of agent depends on disease type, prior therapy and patient risk factors.
How should Mitoxantron ebewe be stored and handled?+
The product must be stored refrigerated at 2‑8 °C, protected from light, and must not be frozen or shaken. It should be kept in its original packaging until use, and handled with appropriate protective equipment to avoid skin contact or inhalation of the solution.
How is Mitoxantron ebewe administered?+
Mitoxantron ebewe is supplied as an intravenous solution and is administered by a qualified healthcare professional through a controlled IV infusion. The infusion rate and duration are determined by the treating physician according to the prescribed regimen.
What are the most serious risks to watch for with mitoxantrone?+
The most serious risks include cardiotoxicity that can lead to irreversible heart damage, the development of secondary acute leukemia, and severe infections resulting from profound neutropenia. Patients should be monitored closely for cardiac function, blood counts and signs of infection.
Who should not use mitoxantrone?+
Mitoxantrone is contraindicated in patients with known hypersensitivity to the drug or its excipients, in those with uncontrolled cardiac disease, and in pregnant or nursing women unless the potential benefit outweighs the risk. Caution is also advised for patients with severe hepatic impairment.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Mitoxantrone
Route
Intravenous Use
Manufacturer
Ebewe Pharma
Origin
EU

Related products

Mitoxan

Mitoxan

Mitoxantrone

Medicamerc S.A
EU
Mitoxantron Accord

Mitoxantron Accord

Mitoxantrone

Accord Healthcare B.V.
EU
Mitoxantron Ebewe

Mitoxantron Ebewe

Mitoxantrone

Ebewe Pharma
EU
Mitoxantron Ebewe

Mitoxantron Ebewe

Mitoxantrone

Ebewe Pharma
EU